Previous studies have shown that Grb2 can modulate EMT via the Snail transcription factor (Mitra et al., 2018) and via the SHP2/Grb2/PI3K/AKT signaling cascade in lung cancer (Wang et al., 2022). This evidence concerns the gene AKT1 and lung carcinoma.